Clinical Trials Browser

Approved for marketing × HhAntag691 × Clear all

NCT01160250 2015-08-06

A Study of Vismodegib (GDC-0449) in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma

Approved for marketing

Carcinoma, Basal Cell